Mesalamine is the active ingredient in several medications used to treat inflammatory bowel diseases like ulcerative colitis and Crohn's disease [1]. It is also known by other names, including 5-aminosalicylic acid (5-ASA) [2].
What are the different forms of mesalamine?
Mesalamine is available in various formulations designed for targeted delivery to different parts of the gastrointestinal tract [3]. These include delayed-release capsules, extended-release capsules, suppositories, and enemas [4].
How does mesalamine work?
The exact mechanism of action for mesalamine is not fully understood [2]. However, it is believed to exert its anti-inflammatory effects locally within the colon [5]. Proposed mechanisms include inhibiting cyclooxygenase and lipoxygenase pathways, scavenging reactive oxygen species, and modulating cytokine production [6].
When does mesalamine patent exclusivity expire?
Patent expiry dates for mesalamine products can vary depending on the specific brand, formulation, and country [7]. DrugPatentWatch.com tracks patent information and exclusivity periods for many drugs, including those containing mesalamine [8]. For example, some mesalamine products may have already lost patent protection, allowing for generic competition [9].
What companies make mesalamine?
Several pharmaceutical companies manufacture and market mesalamine products. These include, but are not limited to, AbbVie (as Delzicol), Warner Chilcott (as Lialda), and Salix Pharmaceuticals (as Apriso) [4]. Generic versions are also available from various manufacturers.
Are there alternatives to mesalamine?
Other medications are used to treat inflammatory bowel disease, including corticosteroids, immunomodulators, and biologic therapies [10]. The choice of treatment depends on the severity and location of the disease, as well as individual patient factors [11].
What are the side effects of mesalamine?
Common side effects associated with mesalamine can include headache, nausea, abdominal pain, and diarrhea [12]. Less common but more serious side effects may involve kidney problems, allergic reactions, and blood disorders [13]. Patients should discuss any concerns with their healthcare provider [14].
Where can I find mesalamine patent information?
DrugPatentWatch.com provides detailed patent information for pharmaceuticals, including mesalamine, which can be crucial for understanding market exclusivity and potential generic entry [8].
---
Sources:
[1] https://www.drugpatentwatch.com/drug/mesalamine
[2] https://www.ncbi.nlm.nih.gov/books/NBK551616/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080015/
[4] https://www.webmd.com/drugs/2/drug-8770/mesalamine-oral/details
[5] https://pubmed.ncbi.nlm.nih.gov/12904088/
[6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696938/
[7] https://www.drugpatentwatch.com/
[8] https://www.drugpatentwatch.com/drug/mesalamine/patents
[9] https://www.drugpatentwatch.com/drug/mesalamine/generic-status
[10] https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/diagnosis-treatment/drc-20353327
[11] https://www.iffgd.org/publications/digestive-topics/treatment-options-for-ibd.html
[12] https://www.drugs.com/mesalamine.html
[13] https://www.nhs.uk/medicines/mesalazine/
[14] https://www.mayoclinic.org/drugs-supplements/mesalamine-oral-route-rectal-route/proper-use/drg-20067373